BIO.News Newsletter

We have details on Biden’s National Cancer Plan—and why price controls may stop innovation in its tracks. Plus, everyone’s talking about AI, so we look at how biotech’s using it to make tasty protein alternatives. (499 words, 2 minutes, 29 seconds)

After a whirlwind week on Capitol Hill, Congress is in recess. Today, we explore how CRISPR might reverse the damage after a heart attack and how plant-based bioplastics can reduce the waste after a snack attack. (498 words, 2 minutes, 29 seconds)

A busy week in Washington wraps with a Senate hearing on PBMs, House hearings on agriculture, and the final day of the USITC’s hearing on the expansion of the COVID IP waiver. (748 words, 3 minutes, 44 seconds)

We’ve packed a lot in today’s issue: BIO’s testimony on the TRIPS waiver at the USITC, a new poll that shows support from voters in both parties for pandemic preparedness, and a recap of CSBA’s Capitol Hill fly-in—plus, a few things you missed on the Hill. (599 words, 2 minutes, 59 seconds)

We recap what HHS Secretary Becerra said yesterday about everything from drug pricing to PBMs, and get ready for more hearings today, including the USITC’s hearing on the COVID IP waiver. (674 words, 3 minutes, 22 seconds)

In the lull before the hearing storm, listen to the new episode of the I am BIO Podcast, which explains why Accelerated Approval is so important for patients. Plus, we look at legislation that would increase tax breaks for R&D. (729 words, 3 minutes, 38 seconds)

We’re gearing up for another busy week in Washington—but first, what USTR said about biotech corn on Friday and why we need to act on a rapidly spreading fungus. (450 words, 2 minutes, 15 seconds)

Happy Friday. A busy week on Capitol Hill concludes with hearings covering key issues including Mexico’s biotech corn ban, expanding the COVID IP waiver, and upholding the purpose of Bayh-Dole—we have a quick recap. (641 words, 3 minutes, 12 seconds)

A busy week continues with yesterday’s hearings on the price of Moderna’s COVID-19 vaccine, the proposed HHS budget, and important PBM transparency legislation—with lots of discussion on priority issues for BIO members. Highlights below—plus, what we would ask USTR today. (733 words, 3 minutes, 39 seconds)

A busy day includes the Senate HELP Committee hearing with Moderna—here’s what we’re watching. Plus, today is World Water Day—and the first major UN water conference since the 1970s—so we’re looking at the role for biotech. (628 words, 3 minutes, 8 seconds)